HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shuji Terao Selected Research

val-valacyclovir

12/2007Long-term outcome of phase I/II clinical trial of Ad-OC-TK/VAL gene therapy for hormone-refractory metastatic prostate cancer.
6/2006Progress report on phase I/II clinical trial of Ad-OC-TK plus VAL therapy for metastatic or locally recurrent prostate cancer: Initial experience at Kobe University.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shuji Terao Research Topics

Disease

6Neoplasms (Cancer)
01/2014 - 07/2005
5Renal Cell Carcinoma (Grawitz Tumor)
05/2013 - 10/2005
5Urinary Bladder Neoplasms (Bladder Cancer)
08/2012 - 07/2005
5Prostatic Neoplasms (Prostate Cancer)
01/2010 - 02/2005
2Neoplasm Metastasis (Metastasis)
01/2010 - 12/2007
1Pain (Aches)
05/2009
1Infections
11/2007
1Hemorrhage
05/2006
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2005
1Carcinoma (Carcinomatosis)
05/2005

Drug/Important Bio-Agent (IBA)

4Messenger RNA (mRNA)IBA
11/2010 - 10/2005
4OsteocalcinIBA
05/2009 - 02/2005
3Thymidine KinaseIBA
05/2009 - 06/2006
3Hormones (Hormone)IBA
05/2009 - 06/2006
2EnzymesIBA
05/2013 - 01/2009
2Proteins (Proteins, Gene)FDA Link
05/2013 - 05/2010
2Zoledronic Acid (Zometa)FDA Link
11/2010 - 01/2010
2val-valacyclovirIBA
12/2007 - 06/2006
1Galectin 3 (LGALS3)IBA
05/2013
1Phosphopyruvate Hydratase (Enolase)IBA
05/2013
1Galectin 1 (LGALS1)IBA
05/2013
1CalnexinIBA
05/2013
1Mannose-Binding Lectin (Mannan-Binding Lectin)IBA
05/2013
1ImmunosorbentsIBA
05/2013
1Tumor Biomarkers (Tumor Markers)IBA
05/2013
1IntegrinsIBA
08/2012
1Interferon-alpha (Interferon Alfa)IBA
01/2011
1CytokinesIBA
01/2011
1LigandsIBA
11/2010
1Valproic Acid (Depakote)FDA LinkGeneric
11/2010
1adenovirus receptorIBA
05/2010
1Diphosphonates (Bisphosphonates)IBA
01/2010
1AndrogensIBA
01/2010
1Prostate-Specific Antigen (Semenogelase)IBA
05/2009
1Valacyclovir (Valtrex)FDA LinkGeneric
05/2009
1Thymidine PhosphorylaseIBA
01/2009
1Fluorouracil (Carac)FDA LinkGeneric
01/2009
1Formaldehyde (Formol)FDA Link
01/2009
1Hydrogenase (Ferredoxin Hydrogenase)IBA
01/2009
1Orotate PhosphoribosyltransferaseIBA
01/2009
1ParaffinIBA
01/2009
1ProdrugsIBA
01/2009
1Thymidylate SynthaseIBA
01/2009
1DNA (Deoxyribonucleic Acid)IBA
11/2007
1MidkineIBA
11/2007
1nafamostatIBA
05/2006
1Protease Inhibitors (Protease Inhibitor)IBA
05/2006
1AnticoagulantsIBA
05/2006
1ErbB Receptors (EGF Receptor)IBA
10/2005
1Gefitinib (Iressa)FDA Link
10/2005
1Interleukin-2 (IL2)IBA
07/2005
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
05/2005

Therapy/Procedure

5Therapeutics
01/2014 - 07/2005
2Drug Therapy (Chemotherapy)
01/2009 - 08/2008
1Lasers (Laser)
01/2009
1Radiotherapy
08/2008
1Extracorporeal Circulation
05/2006
1Intramuscular Injections
07/2005